Mariner LLC Increases Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Mariner LLC lifted its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 103.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 491,550 shares of the medical instruments supplier's stock after buying an additional 250,219 shares during the period. Mariner LLC owned approximately 0.25% of DENTSPLY SIRONA worth $9,330,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also made changes to their positions in the stock. Pacer Advisors Inc. lifted its stake in DENTSPLY SIRONA by 15,105.1% during the fourth quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier's stock worth $85,478,000 after purchasing an additional 4,473,972 shares during the last quarter. Nuance Investments LLC lifted its stake in DENTSPLY SIRONA by 25.0% during the fourth quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier's stock worth $257,103,000 after purchasing an additional 2,708,097 shares during the last quarter. Norges Bank bought a new stake in DENTSPLY SIRONA during the fourth quarter worth $45,730,000. Cooke & Bieler LP lifted its stake in shares of DENTSPLY SIRONA by 24.3% in the 4th quarter. Cooke & Bieler LP now owns 9,172,876 shares of the medical instruments supplier's stock valued at $174,101,000 after acquiring an additional 1,794,391 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its stake in shares of DENTSPLY SIRONA by 206.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier's stock valued at $49,990,000 after acquiring an additional 1,244,326 shares during the last quarter. 95.70% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other news, Director Gregory T. Lucier acquired 15,142 shares of the stock in a transaction dated Monday, March 3rd. The stock was purchased at an average cost of $16.51 per share, with a total value of $249,994.42. Following the completion of the purchase, the director now owns 81,971 shares in the company, valued at approximately $1,353,341.21. The trade was a 22.66 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 0.52% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several research analysts have commented on XRAY shares. Robert W. Baird cut their target price on DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating on the stock in a report on Friday, February 28th. Jefferies Financial Group downgraded shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating and dropped their price target for the stock from $30.00 to $20.00 in a research report on Thursday, January 23rd. Needham & Company LLC restated a "hold" rating on shares of DENTSPLY SIRONA in a research report on Thursday, March 13th. StockNews.com downgraded shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research report on Friday, February 28th. Finally, Morgan Stanley downgraded shares of DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 target price on the stock. in a research report on Tuesday, April 15th. Thirteen research analysts have rated the stock with a hold rating and two have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $22.58.

DENTSPLY SIRONA Price Performance

Shares of XRAY traded up $0.35 during mid-day trading on Thursday, reaching $13.63. 481,497 shares of the stock traded hands, compared to its average volume of 2,949,750. The firm has a fifty day moving average price of $15.28 and a 200 day moving average price of $18.48. The company has a market cap of $2.72 billion, a price-to-earnings ratio of -6.58, a price-to-earnings-growth ratio of 1.80 and a beta of 0.92. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA Inc. has a 1 year low of $12.16 and a 1 year high of $31.00.

DENTSPLY SIRONA Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, April 11th. Stockholders of record on Friday, March 28th were given a dividend of $0.16 per share. The ex-dividend date was Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.70%. DENTSPLY SIRONA's dividend payout ratio (DPR) is currently -14.07%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.